The stroke research team has been established since 2006 participating in both commercial and academic stroke trials. The stroke research team was invited to present at The American Heart and Stroke Association annual conference with the findings of our own study.

Current studies:

  • Huawei - Evaluation of Huawei Smartwear for Detection of Atrial Fibrillation in a post stroke population.
  • Tich-3 - Tranexamic acid for Intracerebral Haemorrhage.
  • Commits - Confirming the Mechanism of Motivational Interviewing therapy after Stroke.
  • Oceanic - Phase 3 study to investigate the efficacy and safety of the oral FXIA  Inhibitor asundexian (BAY2433334) compared with participants after an  acute non cardioembolic ischemic stroke or high risk.

Contact us

Call 0151 706 2914.